Efficacy of five-element gymnastics in glucose and lipid control in taiwanese patients with type 2 diabetes

被引：6
|
作者：
Huang, Chiu-Ling [2 ]
Tai, Yen-Kuang [3 ]
Yang, Yi-Hsin [4 ]
Wang, Ruey-Hsia [1 ]
机构：
[1] Kaohsiung Med Univ, Coll Nursing, Kaohsiung 807, Taiwan
[2] Yuans Gen Hosp, Dept Nursing, Kaohsiung, Taiwan
[3] Yuans Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Dept Pharm, Coll Pharm, Kaohsiung 807, Taiwan
来源：
RESEARCH IN NURSING & HEALTH | 2012年 / 35卷 / 04期
关键词：
diabetes mellitus; five-element gymnastics; glucose; lipidemia; CORONARY-HEART-DISEASE; RISK-FACTORS; EXERCISE; ASSOCIATION; METAANALYSIS; STATEMENT; ADULTS;
D O I：
10.1002/nur.21480
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
The purpose of this quasi-experimental study was to determine the efficacy of Five-Element Gymnastics (FEG) in controlling glycosylated hemoglobin (HbA1C), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) at the 8th and the 16th weeks of intervention for patients with type 2 diabetes in Taiwan. FEG consolidates several traditional Chinese exercises including Qigong, Xiang Gong, and martial arts with gymnastics. The experimental group (n?=?31) practiced FEG at home for 16 weeks. The control group (n?=?35) maintained usual activities. FEG was associated with decrease of HbA1C, TG, and LDL-C levels at the 8th week and continuous decrease of HbA1C through the 16th week. FEG could be an exercise choice for patients with type 2 diabetes. (c) 2012 Wiley Periodicals, Inc. Res Nurs Health 35:419429, 2012
引用
收藏
页码：419 / 429
页数：11
相关论文
共 50 条
  • [1] Effect of glucose control on lipid levels in patients with type 2 diabetes
    Parhofer, KG
    Laubach, E
    Geiss, HC
    Otto, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (18) : 958 - 962
  • [2] The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes
    Egan, JW
    Mathisen, AL
    DIABETES, 2000, 49 : A105 - A105
  • [3] Balaglitazone, a new thiazotidinedionc, improves glucose and lipid control in patients with type 2 diabetes
    Koev, D
    Ionescu-Trgoviste, C
    Rosenthal, A
    Palacios, RTY
    Söder-Ström, J
    Zdravkovic, M
    DIABETES, 2003, 52 : A124 - A124
  • [4] The effect of pioglitazone on glucose control and lipid profile in patients with type 2 diabetes.
    Mathisen, AL
    Schneider, R
    Rubin, C
    Houser, V
    DIABETOLOGIA, 1999, 42 : A227 - A227
  • [5] Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus
    Lalic, N. M.
    Antic, Micic S.
    Bajovic, L.
    Pantelinac, P.
    Jotic, A.
    Kendereski, A.
    Dimic, D.
    Djukic, A.
    Mitrovic, M.
    Vujasin, M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2895 - 2901
  • [6] The effect of pioglitazone an glucose control and lipid profile with type 2 diabetes
    Mathisen, A
    Geerlof, J
    Houser, V
    DIABETES, 1999, 48 : A102 - A103
  • [7] Intensive glucose control in patients with type 2 diabetes
    Hey-Hadavi, JH
    Tuck, C
    Solowiejczyk, J
    Almeida, K
    Goland, RS
    DIABETES, 1999, 48 : A348 - A349
  • [8] Cinnamon and Diabetes: Efficacy on Blood Glucose Level in Patients with Type 2 Diabetes
    Thenmozhi, P.
    Bhuvaneshwari, S.
    Trends in Biomaterials and Artificial Organs, 2022, 36 (01): : 48 - 52
  • [9] Tesaglitazar improves glucose and lipid abnormalities in patients with type 2 diabetes
    Goldstein, BJ
    Rosenstock, J
    Anzalone, D
    Tou, C
    Öhman, P
    DIABETES, 2005, 54 : A21 - A21
  • [10] Tesaglitazar corrects glucose and lipid abnormalities in patients with type 2 diabetes
    Goldstein, B
    Rosenstock, J
    Tou, C
    Anzalone, D
    Öhman, P
    DIABETOLOGIA, 2005, 48 : A274 - A274
12345